The European Commission, EC, has rejected Emotra’s application, submitted in January 2017, for approximately 3 MEUR, intended for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Similar to last time, the application cleared the threshold for all the important criteria and was awarded a second “Seal of Excellence”. We will be submitting a new, revised application as soon as possible. It is quite normal for several applications to be rejected before the EC grants one. The fact that this application was rejected does not affect the Company’s market launch plans.